Update on cystic hydatid disease

Enrico Brunetti, Thomas Junghanss

Research output: Contribution to journalArticle

Abstract

Purpose of review: Cystic echinococcosis, or cystic hydatidosis, is a complex, chronic disease with a cosmopolitan distribution. In humans, its clinical spectrum ranges from asymptomatic infection to severe, rarely even fatal disease. Four approaches in clinical management exist: surgery, percutaneous techniques and drug treatment for active cysts, and the so-called watch and wait approach for inactive cysts. Allocation of patients to these treatments should be based on cyst stage, size and location, available clinical expertise and comorbidities. However, clinical decision algorithms, efficacy, relapse rates, and costs have never been properly evaluated.We review the currently available evidence for clinical decision-making and discuss ways to improve standards of care of one of the most neglected infectious diseases. Recent findings: Data are mostly derived from case series and small clinical trials, and treatment guidelines remain at the level of expert opinion. No single high-quality comparative clinical trial of the four treatment options is available to resolve important questions such as stage-specific allocation of treatments, adverse events and long-term relapse rates. Recent work is beginning to acknowledge this problem. Summary: Currently, four treatment modalities are available for cystic echinococcosis. The level of evidence on which clinicians have to rely is low. For the time being patients should thus be treated in referral centres. Proper comparative clinical trials are urgently needed.

Original languageEnglish
Pages (from-to)497-502
Number of pages6
JournalCurrent Opinion in Infectious Diseases
Volume22
Issue number5
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Echinococcosis
Cysts
Clinical Trials
Therapeutics
Neglected Diseases
Recurrence
Asymptomatic Infections
Expert Testimony
Standard of Care
Communicable Diseases
Comorbidity
Chronic Disease
Referral and Consultation
Guidelines
Costs and Cost Analysis
Pharmaceutical Preparations

Keywords

  • Aspiration
  • Benzimidazoles
  • Cystic echinococcosis
  • Injection of a scolecidal agent and re-aspiration
  • Percutaneous treatment
  • Puncture
  • Surgery
  • Watch and wait

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Update on cystic hydatid disease. / Brunetti, Enrico; Junghanss, Thomas.

In: Current Opinion in Infectious Diseases, Vol. 22, No. 5, 10.2009, p. 497-502.

Research output: Contribution to journalArticle

Brunetti, Enrico ; Junghanss, Thomas. / Update on cystic hydatid disease. In: Current Opinion in Infectious Diseases. 2009 ; Vol. 22, No. 5. pp. 497-502.
@article{ad7f89a7bba148d09f27454fd872fcf7,
title = "Update on cystic hydatid disease",
abstract = "Purpose of review: Cystic echinococcosis, or cystic hydatidosis, is a complex, chronic disease with a cosmopolitan distribution. In humans, its clinical spectrum ranges from asymptomatic infection to severe, rarely even fatal disease. Four approaches in clinical management exist: surgery, percutaneous techniques and drug treatment for active cysts, and the so-called watch and wait approach for inactive cysts. Allocation of patients to these treatments should be based on cyst stage, size and location, available clinical expertise and comorbidities. However, clinical decision algorithms, efficacy, relapse rates, and costs have never been properly evaluated.We review the currently available evidence for clinical decision-making and discuss ways to improve standards of care of one of the most neglected infectious diseases. Recent findings: Data are mostly derived from case series and small clinical trials, and treatment guidelines remain at the level of expert opinion. No single high-quality comparative clinical trial of the four treatment options is available to resolve important questions such as stage-specific allocation of treatments, adverse events and long-term relapse rates. Recent work is beginning to acknowledge this problem. Summary: Currently, four treatment modalities are available for cystic echinococcosis. The level of evidence on which clinicians have to rely is low. For the time being patients should thus be treated in referral centres. Proper comparative clinical trials are urgently needed.",
keywords = "Aspiration, Benzimidazoles, Cystic echinococcosis, Injection of a scolecidal agent and re-aspiration, Percutaneous treatment, Puncture, Surgery, Watch and wait",
author = "Enrico Brunetti and Thomas Junghanss",
year = "2009",
month = "10",
doi = "10.1097/QCO.0b013e328330331c",
language = "English",
volume = "22",
pages = "497--502",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Update on cystic hydatid disease

AU - Brunetti, Enrico

AU - Junghanss, Thomas

PY - 2009/10

Y1 - 2009/10

N2 - Purpose of review: Cystic echinococcosis, or cystic hydatidosis, is a complex, chronic disease with a cosmopolitan distribution. In humans, its clinical spectrum ranges from asymptomatic infection to severe, rarely even fatal disease. Four approaches in clinical management exist: surgery, percutaneous techniques and drug treatment for active cysts, and the so-called watch and wait approach for inactive cysts. Allocation of patients to these treatments should be based on cyst stage, size and location, available clinical expertise and comorbidities. However, clinical decision algorithms, efficacy, relapse rates, and costs have never been properly evaluated.We review the currently available evidence for clinical decision-making and discuss ways to improve standards of care of one of the most neglected infectious diseases. Recent findings: Data are mostly derived from case series and small clinical trials, and treatment guidelines remain at the level of expert opinion. No single high-quality comparative clinical trial of the four treatment options is available to resolve important questions such as stage-specific allocation of treatments, adverse events and long-term relapse rates. Recent work is beginning to acknowledge this problem. Summary: Currently, four treatment modalities are available for cystic echinococcosis. The level of evidence on which clinicians have to rely is low. For the time being patients should thus be treated in referral centres. Proper comparative clinical trials are urgently needed.

AB - Purpose of review: Cystic echinococcosis, or cystic hydatidosis, is a complex, chronic disease with a cosmopolitan distribution. In humans, its clinical spectrum ranges from asymptomatic infection to severe, rarely even fatal disease. Four approaches in clinical management exist: surgery, percutaneous techniques and drug treatment for active cysts, and the so-called watch and wait approach for inactive cysts. Allocation of patients to these treatments should be based on cyst stage, size and location, available clinical expertise and comorbidities. However, clinical decision algorithms, efficacy, relapse rates, and costs have never been properly evaluated.We review the currently available evidence for clinical decision-making and discuss ways to improve standards of care of one of the most neglected infectious diseases. Recent findings: Data are mostly derived from case series and small clinical trials, and treatment guidelines remain at the level of expert opinion. No single high-quality comparative clinical trial of the four treatment options is available to resolve important questions such as stage-specific allocation of treatments, adverse events and long-term relapse rates. Recent work is beginning to acknowledge this problem. Summary: Currently, four treatment modalities are available for cystic echinococcosis. The level of evidence on which clinicians have to rely is low. For the time being patients should thus be treated in referral centres. Proper comparative clinical trials are urgently needed.

KW - Aspiration

KW - Benzimidazoles

KW - Cystic echinococcosis

KW - Injection of a scolecidal agent and re-aspiration

KW - Percutaneous treatment

KW - Puncture

KW - Surgery

KW - Watch and wait

UR - http://www.scopus.com/inward/record.url?scp=70249111882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249111882&partnerID=8YFLogxK

U2 - 10.1097/QCO.0b013e328330331c

DO - 10.1097/QCO.0b013e328330331c

M3 - Article

C2 - 19633552

AN - SCOPUS:70249111882

VL - 22

SP - 497

EP - 502

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 5

ER -